|
시장보고서
상품코드
2054975
진통제 시장 : 약제 클래스별, 적응증별, 제형별, 성분별, 가용성별, 유형별, 성별, 연령층별, 투여 경로별, 유통 채널별, 지역별Analgesics Market, By Drug Class, By Indication, By Dosage Form, By Drug Composition, By Availability, By Type, By Gender, By Age Group, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 진통제 시장은 2026년에 583억 달러로 추계되고 있으며, 2033년까지 929억 9,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.9%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 583억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.90% | 2033년 시장 규모 예측 : | 929억 9,000만 달러 |
세계 진통제 시장의 성장은 전 세계에서 만성 및 급성 통증 질환의 유병률이 증가하고 있는 데 힘입고 있습니다. 진통제는 통증을 완화하고 환자의 삶의 질을 향상시키는 데 있으며, 매우 중요한 역할을 합니다. 생활 방식의 변화와 스트레스 수준 증가로 인해 요통, 관절염, 편두통 등 통증과 관련된 여러 질환이 급격히 증가하고 있습니다. 약물전달 및 제제 개발 분야의 기술적 진보로 인해, 효능이 향상되고 의존성 위험이 낮아진 새로운 진통제에 대한 수요가 증가하고 있습니다. 또한 퇴행성 관절염이나 근골격계 질환에 걸리기 쉬운 고령 인구의 증가 역시 진통제 수요를 끌어올리는 요인이 됩니다. 그러나 오피오이드 계열 약물을 둘러싼 엄격한 규제와 대체요법의 개발은 업계 관계자들에게 과제가 될 수 있습니다.
시장 역학
세계 진통제 시장의 성장은 주로 전 세계적인 고령화에 따라 관절염, 요통, 편두통, 골다공증 등 다양한 통증과 관련된 만성질환의 유병률이 증가하고 있는 데 기인합니다. 추산에 따르면 2030년까지 전 세계 인구의 20% 이상이 퇴행성 관절염에 걸릴 것으로 예상됩니다. 장시간 앉아 있는 업무나 스트레스 증가와 같은 생활 방식의 변화로 인해 근골격계 질환의 발생률이 크게 증가하고 있으며, 그 결과 진통제 수요가 늘어나고 있습니다. 그러나 처방용 오피오이드의 오용 및 남용에 대한 우려가 커지면서 시장 성장이 저해될 가능성이 있습니다. 이에 따라 규제 당국은 오피오이드계 진통제의 승인 및 사용에 관한 규정을 강화하고 있습니다. 또한 칸나비노이드 계열 약물, 침 치료, 물리 치료 등의 대체요법이 점차 보급되고 있으며, 이는 기존 진통제에 대한 수요를 억제할 가능성이 있습니다. 만성 통증 관리에 대한 유리한 보험 급여 정책은 진통제 제조사들에게 수익성이 높은 기회를 제공하고 있습니다. 의존성이 없는 제제 및 첨단 약물전달 시스템 개발을 위한 지속적인 연구는 향후 성장 기회를 가져올 가능성이 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 진통제 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 진통제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 진통제 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 진통제 시장 : 약제 클래스별, 2021-2033년
제5장 세계의 진통제 시장 : 적응증별, 2021-2033년
제6장 세계의 진통제 시장 : 제형별, 2021-2033년
제7장 세계의 진통제 시장 : 약제 조성별, 2021-2033년
제8장 세계의 진통제 시장 : 가용성별, 2021-2033년
제9장 세계의 진통제 시장 : 유형별, 2021-2033년
제10장 세계의 진통제 시장 : 성별, 2021-2033년
제11장 세계의 진통제 시장 : 연령층별, 2021-2033년
제12장 세계의 진통제 시장 : 유통 채널별, 2021-2033년
제13장 세계의 진통제 시장 : 연령층별, 2021-2033년
제14장 세계의 진통제 시장 : 지역별, 2021-2033년
제15장 경쟁 구도
제16장 애널리스트의 제안
제17장 참고 문헌 및 조사 방법
KSA 26.06.18Global Analgesics Market is estimated to be valued at USD 58.30 Bn in 2026 and is expected to reach USD 92.99 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 58.30 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.90% | 2033 Value Projection: | USD 92.99 Bn |
Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved efficacy and reduced risk of addiction. Moreover, growing geriatric population prone to osteoarthritis and musculoskeletal disorders can also boost demand for analgesics. However, strict regulations surrounding opioid medications and development of alternative therapies can pose challenges to industry players.
Market Dynamics
Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global analgesics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Aurobindo Pharma, Bausch Health Companies Inc., Amneal Pharmaceuticals LLC., Apotex Inc., Eli Lilly and Company, Cipla Inc., Lupin
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market
Market Segmentation
- By Drug Class (Revenue, USD Bn, 2021 - 2033)
- Analgesic Combinations (Includes Narcotic Analgesic Combinations)
- Acetaminophen + Aspirin
- Acetaminophen + Aspirin + Caffeine
- Acetaminophen + Butalbital
- Acetaminophen + Butalbital + Caffeine
- Acetaminophen + Caffeine
- Acetaminophen +Caffeine + Isometheptene Mucate
- Acetaminophen + Caffeine + Magnesium Salicylate
- Acetaminophen + Diphenhydramine
- Aspirin + Butalbital + Caffeine
- Codeine + Acetaminophen
- Codeine + Acetaminophen + Butalbital + Caffeine
- Codeine + Aspirin + Butalbital + Caffeine
- Dihydrocodeine + Acetaminophen + Caffeine
- Hydrocodone + Acetaminophen
- Hydrocodone + Ibuprofen
- Ibuprofen + Diphenhydramine
- Naproxen + Diphenhydramine
- Oxycodone + Acetaminophen
- Tramadol + Acetaminophen
- Antimigraine Agents
- Almotriptan
- Dihydroergotamine Nasal
- Eletriptan
- Ergotamine
- Ergotamine + Caffeine
- Frovatriptan
- Naratriptan
- Rizatriptan
- Sumatriptan Injection
- Sumatriptan + Naproxen
- Zolmitriptan
- Cox-2 Inhibitors (Celecoxib)
- Acetaminophen and Miscellaneous Analgesics
- Acetaminophen
- Ziconotide
- Narcotic Analgesics
- Alfentanil
- Buprenorphine
- Butorphanol (Injection)
- Codeine
- Fentanyl
- Hydrocodone
- Hydromorphone
- Levorphanol
- Meperidine
- Methadone
- Morphine
- Nalbuphine
- Oxycodone
- Oxymorphone
- Tramadol
- Tapentadol
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- More COX-1 selective
- Flurbiprofen
- Ketorolac (nasal)
- Ketoprofen
- Tolmetin
- Relatively nonselective
- Ibuprofen
- Naproxen
- Less than 50-fold COX-2 selective
- Indomethacin
- Sulindac
- Piroxicam
- Mefenamic acid
- Meloxicam
- Diclofenac
- Celecoxib
- Etodolac
- Salicylates
- Aspirin
- Diflunisal
- Magnesium salicylate
- Salsalate
- CGRP inhibitors
- Erenumab
- Galcanezumab
- Fremanezumab
- Rimegepant
- Ubrogepant
- Atogepant
- Eptinezumab
- Zavegepant
- More COX-1 selective
- By Indication (Revenue, USD Bn, 2021 - 2033)
- Migraine
- Chronic Migraine
- Migraine Prevention
- Headache and Cluster Headaches
- Allergic Rhinitis
- Anxiety
- Back Pain
- Cold Symptoms
- Fever
- Hangover
- Influenza
- Insomnia
- Muscle Pain
- Osteoarthritis
- Pain
- Pain/Fever
- Period Pain
- Postoperative Pain
- Premenstrual Dysphoric Disorder
- Premenstrual Syndrome
- Rheumatoid Arthritis
- Sinusitis
- Ankylosing Spondylitis
- Chronic Pain
- Familial Adenomatous Polyposis
- High Blood Pressure
- Juvenile Rheumatoid Arthritis
- Spondylarthritis
- Chiari Malformation
- Eustachian Tube Dysfunction
- Neck Pain
- Plantar Fasciitis
- Sciatica
- Transverse Myelitis
- Cough
- Opioid Use Disorder
- Aseptic Necrosis
- Bartter Syndrome
- Bursitis
- Chronic Myofascial Pain
- Costochondritis
- Diffuse Idiopathic Skeletal Hyperostosis
- Dysautonomia
- Frozen Shoulder
- Gout, Acute
- Inflammatory Conditions
- NSAID-Induced Ulcer Prophylaxis
- Patent Ductus Arteriosus
- Polyarticular Juvenile Idiopathic Arthritis
- Polymyalgia Rheumatica
- Radiculopathy
- Spondylolisthesis
- Temporomandibular Joint Disorder
- Tendonitis
- Toothache
- Anesthetic Adjunct
- Breakthrough Pain
- Diabetic Peripheral Neuropathy
- Diarrhea
- Labor Pain
- Light Sedation
- Neonatal Abstinence Syndrome
- Opiate Dependence - Induction
- Opiate Dependence - Maintenance
- Opiate Withdrawal
- Sedation
- Angina
- Angina Pectoris Prophylaxis
- Antiphospholipid Syndrome
- Gas
- Heart Attack
- Indigestion
- Ischemic Stroke
- Ischemic Stroke, Prophylaxis
- Kawasaki Disease
- Lupus
- Myocardial Infarction, Prophylaxis
- Niacin Flush
- Prevention of Thromboembolism in Atrial Fibrillation
- Prosthetic Heart Valves - Thrombosis Prophylaxis
- Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis
- Revascularization Procedures, Prophylaxis
- Rheumatic Fever
- Thromboembolic Stroke Prophylaxis
- Transient Ischemic Attack
- Others
- By Dosage Form (Revenue, USD Bn, 2021 - 2033)
- Tablet
- Capsule
- Injectable
- Patches
- Roll On
- Spray
- Creams, Gels and Ointments
- Others (Suppository, Nasal etc.)
- By Drug Composition (Revenue, USD Bn, 2021 - 2033)
- Single
- Combination
- By Availability (Revenue, USD Bn, 2021 - 2033)
- OTC
- Rx
- By Type (Revenue, USD Bn, 2021 - 2033)
- Branded
- Generics
- By Gender (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- By Age Group (Revenue, USD Bn, 2021 - 2033)
- Pedatric/Infant
- Children
- Adult
- Geriatrics
- By Route of Administration (Revenue, USD Bn, 2021 - 2033)
- Oral/Enteral
- Parenteral
- Topical (Including Patches)
- Others (Rectal, etc.)
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Indication
- Market Snapshot, By Dosage Form
- Market Snapshot, By Drug Composition
- Market Snapshot, By Availability
- Market Snapshot, By Type
- Market Snapshot, By Gender
- Market Snapshot, By Age Group
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Analgesics Market, By Drug Class, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Analgesic Combinations (includes Narcotic Analgesic Combinations)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Acetaminophen + Aspirin
- Acetaminophen + Aspirin + Caffeine
- Acetaminophen + Butalbital
- Acetaminophen + Butalbital + Caffeine
- Acetaminophen + Caffeine
- Acetaminophen +Caffeine + Isometheptene Muscat
- Acetaminophen + Caffeine + Magnesium Salicylate
- Acetaminophen + Diphenhydramine
- Aspirin + Butalbital + Caffeine
- Codeine + Acetaminophen
- Codeine + Acetaminophen + Butalbital + Caffeine
- Codeine + Aspirin + Butalbital + Caffeine
- Dihydrocodeine + Acetaminophen + Caffeine
- Hydrocodone + Acetaminophen
- Hydrocodone + Ibuprofen
- Ibuprofen + Diphenhydramine
- Naproxen + Diphenhydramine
- Oxycodone + Acetaminophen
- Tramadol + Acetaminophen
- Antimigraine Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Almotriptan
- Dihydroergotamine Nasal
- Eletriptan
- Ergotamine
- Ergotamine + Caffeine
- Frovatriptan
- Naratriptan
- Rizatriptan
- Sumatriptan Injection
- Sumatriptan + Naproxen
- Zolmitriptan
- Compound Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Acetaminophen and Miscellaneous Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Acetaminophen
- Ziconotide
- Narcotic Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Alfentanil
- Buprenorphine
- Butorphanol (Injection)
- Codeine
- Fentanyl
- Hydrocodone
- Hydromorphone
- Levorphanol
- Meperidine
- Methadone
- Morphine
- Nalbuphine
- Oxycodone
- Oxymorphone
- Tramadol
- Tapentadol
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Codeine More COX-1 selective
- Flurbiprofen
- Ketorolac (nasal)
- Ketoprofen
- Tolmetin
- Relatively nonselective
- Ibuprofen
- Naproxen
- Less than 50-fold COX-2 selective
- Indomethacin
- Sulindac
- Piroxicam
- Mefenamic acid
- Meloxicam
- Diclofenac
- Celecoxib
- Etodolac
- Salicylates
- Aspirin
- Diflunisal
- Magnesium salicylate
- Salsalate
- CGRP inhibitors
- Erenumab
- Galcanezumab
- Fremanezumab
- Rimegepant
- Ubrogepant
- Atogepant
- Eptinezumab
- Zavegepant
- Codeine More COX-1 selective
5. Global Analgesics Market, By Indication, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Migraine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Chronic Migraine
- Migraine Prevention
- Headache and Cluster Headaches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Allergic Rhinitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anxiety
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Back Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cold Symptoms
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hangover
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Insomnia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Muscle Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain/Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Period Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Postoperative Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Premenstrual Dysphoric Disorder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Premenstrual Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sinusitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ankylosing Spondylitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Chronic Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Familial Adenomatous Polyposis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- High Blood pressure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Juvenile Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Spondylarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Chiari Malformation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Eustachian Tube Dysfunction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neck Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Plantar Fasciitic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sciatica
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Transverse Myelitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cough
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Opioid Use Disorder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Aseptic Necrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bartter Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bursitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Chronic Myofacial Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Costochondritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diffuse Idiopathic Skeletal Hyperostosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dysautonomia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Frozen Shoulder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gout, Acute
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Inflammatory Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- NSAID-Induced Ulcer Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Patent Ductus Arteriosus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Polymyalgia Rheumatica
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Radiculopathy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Spondylolisthesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Temporomandibular Joint Disorder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tendonitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Toothache
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Aesthetic Adjunct
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Breakthrough Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diabetic Peripheral Neuropathy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diarrhea
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Labor Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Light Sedation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neonatal Abstinence Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Opiate Dependence - Induction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Opiate Dependence - Maintenance
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Opiate Withdrawal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sediation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Angina
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Angina Pectoris Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antiphospholipid Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gas
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Heart Attack
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Indigestion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ischemic Stroke
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ischemic Stroke, Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Niacin Flush
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Myocardial Infraction, Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Niacin Flush
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Prevention of Thromboesmbolism in Atrial Fibrillation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Prosthetic Heart Valves- Thrombosis Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Revascularization Procedure, Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Rheumatic Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Thromboembolic Stroke Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Transient Ischemic Attack
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Analgesics Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Tablet
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Capsules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Roll On
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Creams, Gels, and Ointments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (Suppository, Nasal etc)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Analgesics Market, By Drug Composition, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Single
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Combination
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Analgesics Market, By Availability, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- OTC
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Rx
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Analgesics Market, By Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Analgesics Market, By Gender, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
11. Global Analgesics Market, By Age Group, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pedatric/Infant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Children
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Adult
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Geriatrics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
12. Global Analgesics Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
13. Global Analgesics Market, By Age Group, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pedatric/Infant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Children
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Adult
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
14. Global Analgesics Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
15. Competitive Landscape
- Company Profiles
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
17. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
